Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Chun, M.
Right arrow Articles by Oh, Y.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chun, M.
Right arrow Articles by Oh, Y.-T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 31:279-283 (2001)
© 2001 Foundation for Promotion of Cancer Research

High Dose Rate Interstitial Brachytherapy in Soft Tissue Sarcoma: Technical Aspects and Results

Mison Chun1, Seunghee Kang1, Byoung-Suck Kim2 and Young-Taek Oh1,+,§

1Department of Radiation Oncology and 2Department of Orthopedic Surgery, School of Medicine, Ajou University, Suwon, Korea

Background: Radiation is essential for function preservation in the management of soft tissue sarcoma (STS). One of the advantages of brachytherapy is that it allows for specific localization of radiation dose to the tumor bed. We examined the results of our clinical experiences with immediate postoperative high dose rate (HDR) brachytherapy and external beam radiation treatment (EBRT) for STS.

Methods: A total of 17 patients (11 primary and six recurrent) between 1995 and 1999 were included in this review. The inclusion criteria for HDR and EBRT were as follows: (1) high-grade tumor, (2) low-grade tumor of >=10 cm, (3) recurrent tumor, (4) tumor abutting or invading critical structures and (5) positive margin. The catheters (six French) were placed parallel to the long axis of the tumor with a 1–1.5 cm spacing in between. If necessary, muscle or gel-foam was placed over the critical structures to maintain a minimum space of 0.5 cm from the catheters. On postoperative day 6, patients received HDR (2–3 Gy/fraction x6, twice daily). Three weeks later, patients received EBRT (total 36–60 Gy). The follow-up duration was between 13 and 60 months (median 31 months).

Results: There was no local failure within the radiation field in any of the patients. One patient required wound revision for delayed healing after brachytherapy. During EBRT, most patients experienced only mild erythema (grade 1 or 2 skin reaction). In long-term follow-up, there were no patients with neuropathy or significant fibrosis.

Conclusions: Our results suggest that immediate postoperative HDR with a total dose of 12–18 Gy over 3 days is an effective treatment combined with EBRT in the management of STS.

+ For reprints and all correspondence: Mison Chun, Department of Radiation Oncology, Ajou University, San 5 Woncheon-Dong, Padal-Gu, Suwon 442–721, Korea. E-mail: chunm@madang.ajou.ac.kr

§ Abbreviations: STS, soft tissue sarcoma; LDR, low dose rate; HDR, high dose rate; EBRT, external beam radiation therapy; POD, postoperative day; TLD, thermoluminescence dosimeter; NED, no evidence of disease; DWD, dead with disease; DFS, disease-free survival; AWD, alive with disease; MPNST, malignant peripheral nerve sheath tumor; MFH, malignant fibrous histiocytoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
T. Inoue
Perioperative High Dose Rate Brachytherapy for Soft Tissue Sarcoma
Jpn. J. Clin. Oncol., June 1, 2001; 31(6): 237 - 239.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.